Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer-Allergan deal: A boon to shareholders, a blow to R&D
Pfizer-Allergan deal: A boon to shareholders, a blow to R&D
Pfizer-Allergan deal: A boon to shareholders, a blow to R&D
Submitted by
admin
on November 23, 2015 - 9:12pm
Source:
Stat
News Tags:
Pfizer
Allergan
M&A
R&D
Headline:
Pfizer-Allergan deal: A boon to shareholders, a blow to R&D
Do Not Allow Advertisers to Use My Personal information
